$LGND LIGAND PHARMACEUTICALS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in LIGAND PHARMACEUTICALS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
LIGAND PHARMACEUTICALS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALIPRANDI GIAMBATTISTA | Sr.V-P, Tech, Sup & Intl Oper | 0 | 0 | Jun 03 2004 | |||
| Aryeh Jason | Director | 68,664 | 7,404,726 | Jun 07 2021 | |||
| Aryeh Jason | Director | 57,412 | 6,191,310 | Jan 05 2015 | |||
| Aryeh Jason | Director | 285,036 | 30,738,282 | Jun 05 2012 | |||
| Berkman Charles S | SVP, Gen. Counsel & Secretary | 47,003 | 5,068,804 | Feb 05 2021 | |||
| Berkman Charles S | VP, Gen. Counsel & Secretary | 17,328 | 1,868,652 | Mar 08 2012 | |||
| Berkman Charles S | VP, Gen. Counsel & Secretary | 31,989 | 3,449,694 | Feb 11 2015 | |||
| BLISSENBACH HENRY F | Director | 0 | 0 | Jan 06 2004 | |||
| BLISSENBACH HENRY F | Director | 0 | 0 | Jan 05 2005 | |||
| BLISSENBACH HENRY F | Director | 15,005 | 1,618,139 | Apr 04 2007 | |||
| Boyce Sarah | Director | 2,892 | 311,873 | Jun 07 2021 | |||
| BROADDUS WARNER R | V-P, Gen. Counsel & Secy. | 2,428 | 261,836 | Jun 03 2004 | |||
| BROADDUS WARNER R | V-P, Gen. Counsel & Secy. | 0 | 0 | Nov 21 2006 | |||
| Burakoff Steven J | Director | 15,000 | 1,617,600 | Feb 19 2010 | |||
| BVF PARTNERS L P/IL | 10% Owner | 13,537,275 | 1,459,859,736 | Dec 09 2008 | |||
| BVF PARTNERS L P/IL | 10% Owner | 2,008,834 | 216,632,659 | Nov 29 2013 | |||
| BVF PARTNERS L P/IL | 10% Owner | 16,006,215 | 1,726,110,226 | Jan 27 2009 | |||
| BVF PARTNERS L P/IL | 10% Owner | 130,175 | 14,038,072 | Mar 26 2014 | |||
| CROSS ALEXANDER D | Director | 6,001 | 647,148 | May 27 2004 | |||
| CROSS ALEXANDER D | Director | 0 | 0 | Jan 05 2005 | |||
| CROSS ALEXANDER D | Director | 26,335 | 2,839,966 | Jan 05 2007 | |||
| CROUCH TAYLOR | Sr. V-P, Ops & Pres. Int'l | 0 | 0 | Dec 06 2006 | |||
| Davis Todd C | Director | 47,678 | 5,141,596 | Feb 12 2021 | |||
| Davis Todd C | Director | 35,718 | 3,851,829 | May 31 2012 | |||
| Davis Todd C | Director | 34,353 | 3,704,628 | Jun 05 2014 | |||
| DeSilva Nishan M | VP, Finance & Strategy and CFO | 22,282 | 2,402,891 | May 14 2015 | |||
| DeSilva Nishan M | VP, Corporate Development | 10,000 | 1,078,400 | Feb 13 2012 | |||
| DeSilva Nishan M | VP, Corporate Development | 22,282 | 2,402,891 | Feb 11 2015 | |||
| Dziewanowska Zofia E | VP, Clinical Research | 33,977 | 3,664,080 | Feb 27 2009 | |||
| FOEHR MATTHEW W | President and COO | 167,198 | 18,030,632 | Feb 05 2021 | |||
| FOEHR MATTHEW W | EVP and COO | 36,250 | 3,909,200 | Feb 13 2012 | |||
| FOEHR MATTHEW W | EVP and COO | 68,128 | 7,346,924 | Feb 11 2015 | |||
| FOEHR MATTHEW W | EVP and COO | 43,870 | 4,730,941 | Jun 04 2013 | |||
| Gray Nancy Ryan | Director | 3,702 | 399,224 | Jun 07 2021 | |||
| GREETHAM ELIZABETH M | Director | 10,000 | 1,078,400 | Jun 02 2008 | |||
| GROOM JOHN | Director | 0 | 0 | Jan 06 2004 | |||
| GROOM JOHN | Director | 0 | 0 | Jan 05 2005 | |||
| GROOM JOHN | Director | 16,237 | 1,750,998 | Sep 28 2006 | |||
| GROVES ERIC S | V-P, Project Management | 4,236 | 456,810 | Jun 03 2004 | |||
| GROVES ERIC S | V-P, Project Management | 5,127 | 552,896 | Dec 19 2006 | |||
| Herman Melanie J | Director of Accounting | 3,454 | 372,479 | Jul 05 2016 | |||
| HIGGINS JOHN L | Chief Executive Officer | 340,696 | 36,740,657 | Feb 09 2021 | |||
| HIGGINS JOHN L | President & CEO | 136,044 | 14,670,985 | Feb 11 2015 | |||
| HIGGINS JOHN L | President & CEO | 120,025 | 12,943,496 | Jun 04 2013 | |||
| HIGGINS JOHN L | President & CEO | 333,138 | 35,925,602 | Jan 28 2010 | |||
| HIGGINS JOHN L | President & CEO | 108,275 | 11,676,376 | May 08 2012 | |||
| JOHNSON IRVING S | Director | 22,929 | 2,472,663 | Dec 02 2003 | |||
| JOHNSON IRVING S | Director | 0 | 0 | Jan 05 2005 | |||
| JOHNSON IRVING S | Director | 0 | 0 | Jan 05 2007 | |||
| Kazmi Syed | VP, Bus. Dev. & Strategic Plan | 57,710 | 6,223,446 | Jan 28 2010 | |||
| Kazmi Syed | VP, Bus. Dev. & Strategic Plan | 18,230 | 1,965,923 | Feb 13 2012 | |||
| KNOTT DAVID M | Director | 66,152 | 7,133,832 | Aug 19 2015 | |||
| KNOTT DAVID M | Director | 69,227 | 7,465,440 | Oct 10 2014 | |||
| Korenberg Matthew E | EVP,Finance & Strategy and CFO | 41,752 | 4,502,536 | Feb 05 2021 | |||
| KOZARICH JOHN W | Director | 34,543 | 3,725,117 | May 13 2021 | |||
| KOZARICH JOHN W | Director | 0 | 0 | Jan 05 2005 | |||
| KOZARICH JOHN W | Director | 25,378 | 2,736,764 | Jun 02 2008 | |||
| KOZARICH JOHN W | Director | 33,615 | 3,625,042 | May 31 2012 | |||
| KOZARICH JOHN W | Director | 49,286 | 5,315,002 | Oct 15 2014 | |||
| LAMATTINA JOHN L | Director | 24,768 | 2,670,981 | Jun 12 2020 | |||
| LAMATTINA JOHN L | Director | 20,055 | 2,162,731 | Nov 26 2014 | |||
| LAMATTINA JOHN L | Director | 21,535 | 2,322,334 | May 31 2012 | |||
| LIGAND PHARMACEUTICALS INC | 10% Owner | 5,968,083 | 643,598,071 | Aug 27 2020 | |||
| LITALIEN JAMES J | Sr. V-P, Reg Affairs & Comp. | 0 | 0 | Jun 03 2004 | |||
| LITALIEN JAMES J | Sr. V-P, Reg Affairs & Comp. | 0 | 0 | Mar 14 2006 | |||
| Loeb Daniel S | Director | 2,027,378 | 218,632,444 | Mar 28 2007 | |||
| Loeb Daniel S | Director | 0 | 0 | Dec 12 2005 | |||
| MAIER PAUL V | Sr. V-P, CFO | 50,929 | 5,492,183 | Jun 03 2004 | |||
| MAIER PAUL V | Sr. V-P, CFO | 89,310 | 9,631,190 | Sep 08 2004 | |||
| MAIER PAUL V | Sr. V-P, CFO | 84,951 | 9,161,116 | Nov 22 2006 | |||
| MEGLASSON MARTIN | V-P, Discovery Research | 500 | 53,920 | Nov 12 2004 | |||
| MEGLASSON MARTIN | V-P, Discovery Research | 67,000 | 7,225,280 | Jan 28 2010 | |||
| MEGLASSON MARTIN | V-P, Discovery Research | 102,250 | 11,026,640 | May 11 2010 | |||
| MERTES TOD | V-P, Controller & Treasurer | 1,476 | 159,172 | Jun 03 2004 | |||
| MERTES TOD | V-P, Controller & Treasurer | 0 | 0 | Mar 14 2006 | |||
| NEGRO-VILAR ANDRES | Exe V-P, R & D, CSO | 7,233 | 780,007 | Jun 03 2004 | |||
| NEGRO-VILAR ANDRES | Exe V-P, R & D, CSO | 7,233 | 780,007 | Dec 14 2006 | |||
| Patel Sunil | Director | 28,820 | 3,107,949 | Jun 07 2021 | |||
| Patel Sunil | Director | 36,222 | 3,906,180 | May 31 2012 | |||
| Patel Sunil | Director | 41,691 | 4,495,957 | Jun 05 2014 | |||
| PEACOCK BRUCE | Director | 10,000 | 1,078,400 | Dec 24 2008 | |||
| PECK CARL C | Director | 0 | 0 | Jan 06 2004 | |||
| PECK CARL C | Director | 0 | 0 | Jan 05 2005 | |||
| PECK CARL C | Director | 8,378 | 903,484 | Sep 28 2006 | |||
| Perry Jeffrey R | Director | 33,953 | 3,661,492 | Jun 02 2008 | |||
| PETTTIT WILLIAM A | Sr. V-P, HR and Administration | 560 | 60,390 | Jun 03 2004 | |||
| PETTTIT WILLIAM A | Sr. V-P, HR and Administration | 889 | 95,870 | Dec 19 2006 | |||
| Roberts Brigette | Director | 2,378 | 256,444 | Jan 05 2007 | |||
| ROBINSON DAVID E | Pres, CEO & Chairman | 393,643 | 42,450,461 | Mar 24 2004 | |||
| ROBINSON DAVID E | Pres, CEO & Chairman | 411,725 | 44,400,424 | Aug 19 2004 | |||
| ROBINSON DAVID E | Pres, CEO & Chairman | 0 | 0 | Mar 14 2006 | |||
| ROCCA MICHAEL A | Director | 8,000 | 862,720 | Jan 06 2004 | |||
| ROCCA MICHAEL A | Director | 0 | 0 | Jun 22 2004 | |||
| ROCCA MICHAEL A | Director | 11,676 | 1,259,140 | Sep 28 2006 | |||
| Sabba Stephen L | Director | 25,061 | 2,702,578 | Jun 08 2021 | |||
| Sharp John P | VP Finance and CFO | 58,000 | 6,254,720 | Jan 28 2010 | |||
| Sharp John P | VP Finance and CFO | 21,666 | 2,336,461 | Feb 13 2012 | |||
| Sharp John P | VP Finance and CFO | 17,667 | 1,905,209 | Feb 14 2014 |